TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Stock buybacks 2023–2025
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$13.8MFY2025 · since FY2023: $14.0M → $13.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.8M | — |
| FY2023 | $14.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TNXP financial trends
TNXP RevenueTNXP Net incomeTNXP Net marginTNXP Gross profitTNXP Gross marginTNXP Operating incomeTNXP Operating marginTNXP Operating cash flowTNXP Free cash flowTNXP Capital expendituresTNXP Return on equityTNXP Dividends paidTNXP Total assetsTNXP Total liabilitiesTNXP Shareholders’ equityTNXP overview →